Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Heike Mertsching"'
Autor:
Rainer Leyh, Heike Mertsching, Axel Haverich, Mathias Wilhelmi, Klaus Kallenbach, Thorsten Walles, Carmen Puschmann, A. Lichtenberg
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 61:494-494
Autor:
Jörg Heine, Andreas Schmiedl, Matthias Karck, Heike Mertsching, Serghei Cebotari, Axel Haverich, Klaus Kallenbach
Publikováno v:
Artificial Organs. 35:930-940
Suggesting that bioartificial vascular scaffolds cannot but tissue-engineered vessels can withstand biomechanical stress, we developed in vitro methods for preclinical biological material testings. The aim of the study was to evaluate the influence o
Autor:
Andreas Schmiedl, Axel Haverich, Heike Mertsching, Matthias Karck, Klaus Kallenbach, Serghei Cebotari, Jörg Heine
Publikováno v:
Tissue Engineering Part A. 17:1253-1261
Objectives: Tissue-engineered arterial vessels (TEAV) offer substantial advantages in small-calibered human-bypass- grafting and vascularized scaffold applications. However, histological composition of TEAV must allow for functional properties, such
Autor:
Rainer G. Leyh, Sergey Ciboutari, Axel Haverich, Mathias Wilhelmi, Philip Rebe, Heike Mertsching
Publikováno v:
The Annals of Thoracic Surgery. 81(4):1466-1471
BackgroundTissue-engineered pulmonary arteries could overcome the drawbacks of homografts or prosthetic conduits used in the repair of many congenital cardiac defects. However, the ideal scaffold material for tissue-engineered conduits is still subje
Autor:
Fred Hofmann, Bettina Giere, Johanna Schanz, Heike Mertsching, Thorsten Walles, Michael Hofmann, Paolo Macchiarini
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 128:900-906
Objective We sought to grow in vitro functional smooth muscle cells, chondrocytes, and respiratory epithelium on a biologic, directly vascularized matrix as a scaffold for tracheal tissue engineering. Methods Ten- to 15-cm–long free jejunal segment
Autor:
Serghei Cebotari, M. Wilhelmi, Heike Mertsching, Thorsten Walles, Andreas Schmiedl, Rainer G. Leyh, Klaus Kallenbach, Elena Lefik, Axel Haverich
Publikováno v:
Biomaterials. 25:3613-3620
Objective : For cardiovascular tissue engineering, acellularized scaffolds of porcine matrices have been successfully used. However, the possibility of porcine endogenous retrovirus (PERV) transmission remains debatable. In this study, we investigate
Publikováno v:
Zeitschrift f�r Kardiologie. 92:938-946
BACKGROUND The ideal scaffold material for tissue engineered heart valves is discussed controversially. We evaluated acellularized xenogenic matrix constructs with and without seeding with autologous vascular cells in the pulmonary circulation in a s
Autor:
C. G. Stief, Heike Mertsching, Udo Jonas, Norbert Schlote, Köppe M, J. Wefer, Alexander I. Gabouev, Dirk Schultheiss
Publikováno v:
The International Journal of Artificial Organs. 26:935-942
Background: Partial or radical cystectomy requires replacement of the urinary reservoir normally achieved by using small or large bowel segments. Our aim was to establish tissue engineering of an bioartificial bladder wall using primary cultures of p
Autor:
Karsten Knobloch, Uwe Klima, Axel Haverich, A. Krug, Artur Lichtenberg, M. Pichlmaier, Heike Mertsching
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 51:255-259
BACKGROUND: Internal thoracic arterial grafts (ITA) in coronary artery bypass surgery provide excellent long-term patency results. Due to the elevated incidence of sternal infections following pedicled ITA harvesting, blood supply to the sternum has
Autor:
Payam Akhyari, B. Wachsmann, Axel Haverich, Jan Boublik, Theo Kofidis, Arjang Ruhparwar, K. Mueller-Stahl, Heike Mertsching, Robert C. Robbins, Leora B. Balsam
Publikováno v:
ResearcherID
Various types of three-dimensional matrices have been used as basic scaffolds in myocardial tissue engineering. Many of those are limited by insufficient mechanical function, availability, or biocompatibility. We present a clinically established coll